What is Soleno Therapeutics Inc (SLNO)?
Soleno Therapeutics Inc is a biopharmaceutical company focused on the development and commercialization of therapies for rare and debilitating diseases. The company’s research efforts concentrate on genetic and metabolic disorders, aiming to address underlying causes through targeted treatments. Soleno Therapeutics engages in clinical development programs and regulatory activities to advance its product candidates. It operates within the specialty pharmaceutical sector, emphasizing precision medicine approaches. The company collaborates with healthcare professionals and regulatory agencies to support patient access to innovative therapies for conditions with limited treatment options.
Soleno Therapeutics Inc Stock Price Today: Live Overview
The price today is shaped by market activity, as Quantum Computing, Inc. is trading at $33.28. Across the session, the price range has been between $32.56 and $33.59, registering a daily change of -1.2522%.
FAQ: Soleno Therapeutics Inc (SLNO)
What is the current price of SLNO stock?
The current price stands at $33.28.
Does SLNO pay dividends?
Soleno Therapeutics Inc does not pay dividends.
Does SLNO have a formal corporate presence or regional headquarters in the UAE?
Soleno Therapeutics Inc operates in the UAE only through distributors and has no official regional office or subsidiary.
What is SLNO best known for?
Soleno Therapeutics Inc is most famous for developing treatments for rare diseases.
What assets are typically shown together with SLNO?
Commonly shown alongside SLNO: iShares MSCI Europe Health Care Sector UCITS ETF, Dentsply, BTG Consulting PLC
Latest shares articles



